159 related articles for article (PubMed ID: 36423949)
1. Metastatic spread of serous ovarian carcinoma to the bilateral breasts: a rare presentation.
Musa A; Joiner M; Dzul S; Miller SR
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36423949
[TBL] [Abstract][Full Text] [Related]
2. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
[TBL] [Abstract][Full Text] [Related]
3. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
4. Metastasis of serous ovarian carcinoma to the breast: a case report and review of the literature.
Dueño S; Stein R; Jamal M; Lewis G; Hew K
J Med Case Rep; 2024 Mar; 18(1):127. PubMed ID: 38528610
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT in serous psammocarcinoma of the ovary.
Dong A; Wang Y; Zuo C
Clin Nucl Med; 2014 May; 39(5):453-5. PubMed ID: 23510884
[TBL] [Abstract][Full Text] [Related]
6. Atypical location of metastatic ovarian carcinoma detected by (18)F-FDG PET/CT.
Sagasta Urrutia J; Portilla-Quattrociocchi H; Garcia Hernandez D; Montero de la Peña A; Moreno Capdevila C; Tobalina Larrea I
Rev Esp Med Nucl Imagen Mol; 2016; 35(1):58-60. PubMed ID: 26341423
[No Abstract] [Full Text] [Related]
7. Atypical Proliferative (Borderline) Serous Tumor in the Brain: A Case Report.
Xing D; Jenson EG; Zwick CA; Rodriguez FJ; Kurman RJ
Int J Gynecol Pathol; 2018 Jan; 37(1):52-56. PubMed ID: 28700421
[TBL] [Abstract][Full Text] [Related]
8. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment maximum standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic factor for ovarian clear cell carcinoma and low-grade serous carcinoma.
Matsuura T; Otsuka I; Ouchi T; Ouchi E; Asano R; Miyasaka N
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):305-310. PubMed ID: 33678332
[TBL] [Abstract][Full Text] [Related]
10. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall.
Recine MA; Deavers MT; Middleton LP; Silva EG; Malpica A
Am J Surg Pathol; 2004 Dec; 28(12):1646-51. PubMed ID: 15577686
[TBL] [Abstract][Full Text] [Related]
11. Virchow's node metastasis: an unusual presentation of ovarian cancer.
Kemal Y; Kokcu A; Kefeli M; Tosun FC; Demirag G; Kurtoglu E; Yucel I
Eur J Gynaecol Oncol; 2016; 37(3):398-400. PubMed ID: 27352573
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic Resection of a High Grade Serous Ovarian Cancer that Recurred at the Vaginal Stump with Extensive Pelvic Adhesions after Complete Surgical Staging.
Li J; Duan J; Mao R; Jiang W
J Minim Invasive Gynecol; 2022 Mar; 29(3):343-344. PubMed ID: 34871772
[TBL] [Abstract][Full Text] [Related]
13. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
Silva NN; Eng C
J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
[TBL] [Abstract][Full Text] [Related]
14. Metastatic serous carcinoma presenting as inflammatory carcinoma over the breast-Report of two cases and literature review.
Panse G; Bossuyt V; Ko CJ
J Cutan Pathol; 2018 Mar; 45(3):234-239. PubMed ID: 29194708
[TBL] [Abstract][Full Text] [Related]
15. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
16. Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review.
Susini T; Olivieri S; Molino C; Castiglione F; Tavella K; Viligiardi R
J Womens Health (Larchmt); 2010 Jan; 19(1):169-74. PubMed ID: 20088673
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT in Bilateral Breasts Metastasis From Ovarian Carcinoma.
Karanth SS; Malik D; Khanna G; Sen IB; Manda D; Raina V
Clin Nucl Med; 2022 Feb; 47(2):e194-e196. PubMed ID: 35006118
[TBL] [Abstract][Full Text] [Related]
18. A rare case of high-grade serous ovarian epithelial carcinoma presenting as an isolated cystic mediastinal mass: a case report and brief review of the literature.
Scarci M; Attia R; Routledge T; King J
Ann R Coll Surg Engl; 2010 Jul; 92(5):W57-8. PubMed ID: 20529517
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of the metastatic lesion-to-ovarian cancer standardised uptake value ratio in advanced serous epithelial ovarian cancer.
Chung HH; Lee M; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
Eur Radiol; 2017 Nov; 27(11):4510-4515. PubMed ID: 28593431
[TBL] [Abstract][Full Text] [Related]
20. PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma.
Chivukula M; Dabbs DJ; O'Connor S; Bhargava R
Int J Gynecol Pathol; 2009 Nov; 28(6):570-8. PubMed ID: 19851209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
